Citius Oncology, Inc.

Pharmaceutical company · Cranford, New Jersey, United States · Nasdaq: CTOR

Citius Oncology, Inc. is a pharmaceutical company headquartered in Cranford, New Jersey, United States. Its shares trade on Nasdaq under the ticker CTOR.

Profile compiled from public records. Is this your company? Request a correction or update

Citius Oncology at a glance

Typepharmaceutical company

HeadquartersCranford, New Jersey, United States

Stock listingNasdaq: CTOR

SEC industryPharmaceutical Preparations

SEC CIK1851484

Frequently asked questions about Citius Oncology

Where is Citius Oncology headquartered?

Citius Oncology, Inc. is headquartered in Cranford, New Jersey, United States.

What does Citius Oncology do?

Citius Oncology, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Is Citius Oncology a public company?

Yes. Citius Oncology, Inc. trades on Nasdaq under the ticker CTOR.

Similar companies

Citius Pharmaceuticals, Inc.Cranford, New Jersey, United States
AbbVie Inc.North Chicago, Illinois, United States
Savara IncAustin, Texas, United States
Crinetics Pharmaceuticals, Inc.San Diego, California, United States
Cartesian Therapeutics, Inc.Frederick, Maryland, United States
Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
Dare Bioscience, Inc.San Diego, California, United States
Cellectar Biosciences, Inc.Florham Park, New Jersey, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences